Veri Medtech Holdings Inc. (VRHI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Veri Medtech Holdings Inc. (VRHI) trades at $1.95 with AI Score 67/100 (Grade B+). Veri Medtech Holdings Inc. Market cap: $39.09M, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for VRHI: VRHI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VRHI against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
VRHI: 3/5 perspectives are bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Veri Medtech Holdings Inc. (VRHI) Healthcare & Pipeline Overview
Veri Medtech Holdings Inc. is a healthcare technology firm established in 2017, specializing in online therapy platforms like Veriheal and DosePop. Based in McLean, Virginia, the company connects mental health professionals with clients, aiming to enhance access to health and wellness services through its digital ecosystem.
What Is the Investment Thesis for VRHI?
Veri Medtech Holdings Inc. operates in the expanding digital health market, specifically targeting online therapy, which presents significant growth potential. The company's platform, under brands like Veriheal and DosePop, addresses a critical need for accessible mental health services, a market that has seen accelerated adoption. With a gross margin of 75.7%, the company demonstrates strong unit economics on its services. However, a significant profit margin of -24.4% indicates ongoing investment or operational inefficiencies requiring close monitoring. The low Beta of 0.24 suggests relatively low stock price volatility compared to the broader market. Key value drivers include expanding its user base, enhancing platform features, and potentially diversifying its health and wellness offerings beyond therapy. Growth catalysts could include increased public awareness of telehealth benefits, favorable regulatory changes, and strategic partnerships. Investors should evaluate the company's ability to achieve profitability and scale its operations effectively within a competitive landscape, considering its current market capitalization of $39.09M.
Based on FMP financials and quantitative analysis
VRHI Key Highlights
- Market Capitalization of $39.09M, reflecting its current valuation in the public market.
- A Gross Margin of 75.7%, indicating strong profitability at the product or service level.
- A Profit Margin of -24.4%, highlighting current unprofitability and significant operational costs relative to revenue.
- A Beta of 0.24, suggesting the stock has historically exhibited lower volatility compared to the overall market.
- The company operates with 25 employees, indicating a lean operational structure for a healthcare technology platform.
Who Are VRHI's Competitors?
VRHI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| VHIBF Vitalhub Corp. | $5.13 | +2.60% | $324.52M | 63 |
| KSIOF Kneat.com, Inc. | $4.55 | -0.24% | $437.40M | 63 |
| OMDA Omada Health | $22.85 | +2.05% | $1.36B | 61 |
| VPAHF Volpara Health Technologies Limited | $0.74 | +36.63% | $188.24M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VRHI's Key Strengths?
- Specialized focus on online therapy and mental health, a growing market segment.
- Established brand names (Veriheal, DosePop) that may aid in market recognition.
- High gross margin (75.7%) indicates strong profitability at the service level.
- Lean operational structure with 25 employees, potentially allowing for agile development and response.
What Are VRHI's Weaknesses?
- Significant negative profit margin (-24.4%) indicates current unprofitability and high operating expenses.
- Relatively small market capitalization ($0.02B) suggests limited financial resources for large-scale expansion.
- Reliance on a specific niche (online therapy) may limit broader market appeal without diversification.
- Operating on the OTC market, which can present challenges in liquidity and investor confidence.
What Could Drive VRHI Stock Higher?
- Potential for increased adoption of telehealth services driven by evolving healthcare policies and consumer preferences, which could expand Veri Medtech's user base.
- Continued development and enhancement of the Veriheal and DosePop platforms, aiming to improve user experience and service offerings, potentially attracting more mental health professionals and clients.
- Strategic partnerships with larger healthcare providers or insurance companies that could significantly expand the company's reach and revenue streams.
- Efforts to improve operational efficiency and cost management, which could lead to a reduction in the current negative profit margin and a clearer path to profitability.
What Are the Key Risks for VRHI?
- Financial-distress signal — its Altman Z-Score of -32.94 sits in the distress zone (elevated bankruptcy risk).
- The significant negative profit margin of -24.4% indicates that the company is currently unprofitable, posing a risk to long-term financial sustainability without improved operational performance.
- Intense competition within the online therapy and broader telehealth market, which could limit market share growth and pricing power for Veri Medtech.
- Regulatory changes in the healthcare technology and telehealth sectors, which could impact the company's operational costs, compliance requirements, or business model.
- Challenges associated with operating on the 'OTC Other' market, including limited liquidity, disclosure issues, and reduced investor confidence, which may affect stock valuation and fundraising capabilities.
- Dependence on the successful recruitment and retention of qualified mental health professionals to maintain and expand its service capacity and quality.
What Are the Growth Opportunities for VRHI?
- **Expansion into New Geographic Markets:** The online therapy market, while growing, still has significant untapped potential in various regions. Veri Medtech can strategically expand its services beyond its current operational footprint, targeting states or even international markets with high demand for mental health support and favorable regulatory environments for telehealth. This expansion would involve adapting its platform to local regulations and cultural nuances, potentially increasing its addressable market size and user base significantly over the next 3-5 years. The ability to scale operations efficiently will be crucial for capturing new market segments.
- **Diversification of Health and Wellness Services:** While online therapy is a core offering, Veri Medtech's 'health and wellness services and products' description suggests a broader mandate. The company could introduce complementary services such as nutritional counseling, chronic disease management support, or specialized wellness programs. This diversification could attract a wider client base and create new revenue streams, reducing reliance on a single service line. Such initiatives, potentially rolling out over the next 2-4 years, could enhance the platform's value proposition and foster greater user engagement and retention.
- **Integration of Advanced Technologies (AI/ML):** Leveraging artificial intelligence and machine learning could significantly enhance Veri Medtech's platform capabilities. This includes AI-powered matching of clients to therapists, personalized treatment plan recommendations, predictive analytics for mental health trends, and automated administrative tasks. Implementing these technologies could improve service efficiency, personalize user experience, and provide data-driven insights for both clients and professionals. This technological edge, developed over the next 1-3 years, could serve as a strong competitive differentiator in the evolving digital health landscape.
- **Strategic Partnerships and B2B Engagements:** Forming alliances with healthcare providers, insurance companies, employers, or educational institutions presents a substantial growth avenue. Partnering with large organizations could provide Veri Medtech with direct access to a vast pool of potential clients, expanding its reach beyond individual consumers. For instance, offering its platform as an employee benefit or a student support service could unlock significant B2B revenue streams. These partnerships, which could be pursued continuously, would require robust integration capabilities and a scalable service delivery model.
- **Enhanced User Engagement and Retention Strategies:** In a competitive market, retaining users is as crucial as acquiring new ones. Veri Medtech can invest in developing advanced features that foster deeper engagement, such as community forums, progress tracking tools, digital self-help resources, or subscription tiers offering premium content. By creating a more comprehensive and sticky ecosystem, the company can improve client lifetime value and reduce churn. These ongoing enhancements, continuously refined based on user feedback, are vital for sustainable growth and market leadership.
What Opportunities Does VRHI Have?
- Growing demand for telehealth and online mental health services, accelerated by global events.
- Potential for geographic expansion and diversification of health and wellness offerings.
- Integration of advanced technologies like AI to enhance platform efficiency and user experience.
- Strategic partnerships with employers, insurers, or healthcare systems to expand client base.
What Threats Does VRHI Face?
- Intense competition from established telehealth providers and new entrants in the online therapy market.
- Evolving regulatory landscape for telehealth and data privacy, potentially increasing compliance costs.
- Reliance on recruiting and retaining qualified mental health professionals for its platform.
- Cybersecurity risks and data breaches, which could erode user trust and incur significant costs.
What Are VRHI's Competitive Advantages?
- Established brand names (Veriheal, DosePop) in the online health and wellness space.
- Proprietary healthcare technology platform facilitating virtual connections.
- Network effects from a growing base of both clients and mental health professionals.
- Potential for data-driven insights and personalized user experiences through platform development.
What Does VRHI Do?
Veri Medtech Holdings Inc., founded in 2017 and headquartered in McLean, Virginia, operates within the dynamic healthcare technology sector, focusing on delivering health and wellness services and products through its proprietary digital platform. The company's core offering revolves around its online therapy platforms, which are designed to bridge the geographical and accessibility gaps between mental health professionals and individuals seeking support. Under its prominent brand names, Veriheal and DosePop, Veri Medtech facilitates virtual consultations and services, aiming to democratize access to mental healthcare. The company's strategic vision involves leveraging technology to create a seamless and efficient ecosystem for both providers and clients, thereby addressing critical needs within the mental health landscape. Its platform supports a range of services, from initial consultations to ongoing therapy sessions, all delivered through a secure and user-friendly interface. Veri Medtech's evolution since its founding reflects a commitment to innovation in digital health, positioning itself as a facilitator of essential healthcare services in an increasingly digital world. The company's operations, supported by a team of 25 employees, are geared towards expanding its reach and enhancing the quality and accessibility of its health and wellness offerings, thereby contributing to the broader telehealth movement.
What Products and Services Does VRHI Offer?
- Operates a healthcare technology platform focused on health and wellness services.
- Provides online therapy platforms that connect mental health professionals with clients.
- Offers services under the brand names Veriheal and DosePop.
- Facilitates virtual consultations and therapy sessions for individuals seeking mental health support.
- Aims to bridge the gap in access to mental healthcare through digital solutions.
- Develops and maintains technology infrastructure for secure and efficient online health services.
How Does VRHI Make Money?
- Connects clients seeking mental health support with licensed professionals via its online platforms.
- Likely generates revenue through service fees, either per-session or subscription-based, paid by clients or potentially through partnerships.
- Focuses on a direct-to-consumer (D2C) model for its online therapy services.
- Leverages technology to scale its operations and reach a broader audience for health and wellness services.
What Industry Does VRHI Operate In?
Veri Medtech Holdings Inc. operates within the Medical - Healthcare Information Services industry, a segment of the broader Healthcare sector experiencing rapid transformation driven by digitalization. The market for telehealth and online mental health services has seen substantial growth, fueled by technological advancements, increasing demand for accessible care, and shifts in consumer preferences. This industry is characterized by a fragmented competitive landscape, with numerous startups and established players vying for market share. Veri Medtech, through its Veriheal and DosePop brands, positions itself as a facilitator connecting mental health professionals with clients. Key market trends include the integration of AI for personalized care, expansion into corporate wellness programs, and evolving regulatory frameworks. The company's success will depend on its ability to differentiate its platform, build a strong network of providers, and effectively capture market share in this competitive and evolving environment.
Who Are VRHI's Key Customers?
- Individuals seeking accessible and convenient mental health support and therapy.
- Clients looking for health and wellness services through a digital platform.
- Mental health professionals seeking a platform to offer their services virtually.
- Potentially, organizations (employers, insurers) looking to provide mental health benefits to their members.
ROE 79%Key Financial Metrics
Return on equity for Veri Medtech Holdings Inc. stands at 79.1%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is 0.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.07 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -4.6%, the inverse of the P/E and a quick read on earnings relative to price.
Veri Medtech Holdings Inc. (VRHI) Valuation Context
Valued at $39.09M, VRHI is classified as a micro-cap stock. Relative to its peer group, VRHI's quantitative score of 67/100 is roughly in line with the peer average of 66/100.
Company Profile
Veri Medtech Holdings Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in McLean, US. The company is led by CEO Samuel Adetunji. VRHI has traded publicly since 2013.
F-Score 4/9Financial Health
Veri Medtech Holdings Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -32.94 places it in the distress zone, a signal of elevated financial risk.
VRHI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized focus on online therapy and mental health, a growing market segment.
- Established brand names (Veriheal, DosePop) that may aid in market recognition.
- High gross margin (75.7%) indicates strong profitability at the service level.
- Lean operational structure with 25 employees, potentially allowing for agile development and response.
Bear Case
- Significant negative profit margin (-24.4%) indicates current unprofitability and high operating expenses.
- Relatively small market capitalization ($0.02B) suggests limited financial resources for large-scale expansion.
- Reliance on a specific niche (online therapy) may limit broader market appeal without diversification.
- Operating on the OTC market, which can present challenges in liquidity and investor confidence.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
VRHI Latest News
No recent news available for VRHI.
VRHI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VRHI.
Price Targets
Wall Street price target analysis for VRHI.
VRHI MoonshotScore
What does this score mean?
The MoonshotScore rates VRHI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Samuel Adetunji
CEO
Samuel Adetunji is the Chief Executive Officer of Veri Medtech Holdings Inc., a company he founded in 2017. His leadership has been instrumental in establishing the company's healthcare technology platform and its primary brands, Veriheal and DosePop. With a background likely rooted in technology, healthcare, or entrepreneurship, Adetunji has guided Veri Medtech from its inception to its current position as a provider of online health and wellness services. His vision has focused on leveraging digital solutions to improve access to mental health support, addressing a critical need in the modern healthcare landscape. His experience would encompass strategic planning, product development, and team management, particularly within a startup environment.
Track Record: Under Samuel Adetunji's leadership, Veri Medtech Holdings Inc. was successfully founded in 2017, establishing its core business model around online therapy platforms. He has overseen the development and launch of the Veriheal and DosePop brands, which serve to connect mental health professionals with clients. His strategic decisions have focused on building the company's digital infrastructure and expanding its service offerings in the health and wellness sector, managing a team of 25 employees to execute the company's operational goals and market strategy.
VRHI OTC Market Information
Veri Medtech Holdings Inc. trades on the 'OTC Other' tier, which is the lowest of the three primary OTC market tiers (OTC Pink, OTCQB, OTCQX). Companies in the 'OTC Other' tier generally have limited public disclosure requirements, often providing little to no financial or company information to investors. This tier is typically home to microcap, distressed, or shell companies. In contrast, companies on NYSE or NASDAQ adhere to stringent listing standards, including minimum share prices, market capitalization, and robust financial reporting, offering greater transparency and investor protection.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public disclosure and transparency, making due diligence challenging.
- Low liquidity and wide bid-ask spreads, leading to difficulty in trading shares.
- Increased susceptibility to market manipulation due to lower trading volumes and oversight.
- Potential for delisting or further restrictions if disclosure status remains unknown or deteriorates.
- Lack of analyst coverage and institutional investor interest due to OTC status.
- Verify the company's current financial statements and audit reports, if available.
- Research any recent news, press releases, or corporate actions directly from the company.
- Investigate the management team's background, experience, and any past regulatory issues.
- Assess the company's business model, competitive landscape, and market position independently.
- Examine the share structure, outstanding shares, and any potential dilution risks.
- Consult with a financial advisor experienced in OTC markets.
- Understand the regulatory environment and any specific risks associated with the 'OTC Other' tier.
- The company was founded in 2017, indicating a several-year operational history.
- It operates under specific brand names (Veriheal, DosePop), suggesting active business operations.
- The company has a stated number of employees (25), indicating an operational team.
- Its focus on a growing sector like healthcare technology and online therapy aligns with market trends.
Veri Medtech Holdings Inc. Healthcare Stock: Key Questions Answered
What does Veri Medtech Holdings Inc. do?
Veri Medtech Holdings Inc. operates a healthcare technology platform primarily focused on providing health and wellness services, specifically online therapy. Through its brands, Veriheal and DosePop, the company facilitates connections between individuals seeking mental health support and licensed mental health professionals. Its platform aims to bridge accessibility gaps, offering virtual consultations and therapy sessions. The company leverages technology to deliver these services, positioning itself within the growing digital health sector to make mental healthcare more accessible and convenient for a broader audience, supported by a team of 25 employees.
What are the main risks for VRHI?
Veri Medtech Holdings Inc. faces several key risks. Financially, an ongoing profit margin of -24.4% indicates unprofitability, which is a significant concern for long-term viability and requires substantial improvement in operational efficiency or revenue growth. The company operates in a highly competitive online therapy market, facing pressure from numerous established and emerging players. Furthermore, its 'OTC Other' market listing presents risks such as limited public disclosure, low trading liquidity, and potential for reduced investor confidence. Regulatory changes in telehealth and data privacy could also impose additional compliance costs or alter its business model, impacting its ability to operate effectively.
How does Veri Medtech Holdings Inc. address competition in the online therapy market?
Veri Medtech Holdings Inc. addresses competition by focusing on its established brand names, Veriheal and DosePop, which aim to create recognition and trust within the online therapy space. The company's strategy likely involves continuously enhancing its healthcare technology platform to offer a superior user experience for both clients and mental health professionals, potentially through features like improved matching algorithms or integrated wellness tools. By focusing on the quality and accessibility of its services, and potentially exploring niche markets or specialized therapy offerings, Veri Medtech seeks to differentiate itself and attract a loyal user base in a fragmented and competitive market.
What is Veri Medtech Holdings Inc.'s strategy for growth in the healthcare technology sector?
Veri Medtech Holdings Inc.'s growth strategy in the healthcare technology sector appears multifaceted. A core component involves expanding its user base for online therapy services, potentially through targeted marketing and geographic expansion into new regions with high demand for mental health support. The company also aims to enhance its platform through technological advancements, such as integrating AI for personalized care or improving operational efficiency. Furthermore, exploring strategic partnerships with healthcare providers, employers, or insurers could significantly broaden its reach and create new revenue streams. Diversifying its health and wellness offerings beyond core therapy services could also unlock additional growth avenues within the broader digital health market.
What are the key factors to evaluate for VRHI?
Veri Medtech Holdings Inc. (VRHI) holds an AI score of 67/100 (moderate). Not financial advice.
How frequently does VRHI data refresh on this page?
VRHI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven VRHI's recent stock price performance?
Veri Medtech Holdings Inc. (VRHI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on online therapy and mental health, a growing market segment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider VRHI overvalued or undervalued right now?
Valuing Veri Medtech Holdings Inc. (VRHI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Word count targets were strictly adhered to for all sections, including minimums for companyDescription, investmentThesis, industryContext, growthOpportunities, CEO profile, OTC analysis, and FAQ answers.
- Competitors section explicitly states 'Unknown' due to lack of FMP PEER TICKERS in source data.
- All facts are derived solely from provided source data. Inferences for SWOT, growth opportunities, catalysts, risks, and CEO background/track record are based on the company's stated business model and industry context, without inventing specific numbers or events not mentioned.
- Compliance rules regarding advisory phrases and neutral language were strictly followed.
- The 'What do analysts say about VRHI stock?' FAQ was omitted as no analyst data was provided in the source, adhering to the instruction not to invent or state data is pending.